Only few reports are available on the consequences of chronic oral administration of low doses of mercuric chloride (HgClJ. Forty Brown-Nonvay rats received 150 p g HgCIJ100 g body weight 3 times a week by gavage or by i.m. injection with 100 pg twice pcr week. After 2 weeks of oral HgC12 administration, the rats lost weight and hair. Phases of proteinuria were observed in weeks 5-8 and then continuously from week 12 until the end ofthe experiment at week 39. Antibodies binding to renal, intestinal, and vascular basement membrane developed after 2 weeks; circulating immune complexes were detectable in increasing titers starting at week 3. There were linear deposits of IgG, IgM, and IgA in the glomemlar basement membrane and tubular basement membrane, and along the intestinal basement membrane. After week 1 1, the first granular immune deposits wcrc observed in renal and intestinal basement membranes. Light microscopy showed thickcning of glornerular bascment membrane, mesangial matrix, and tubular basement membrane. In addition, interstitial nephritis was observed in some animals. Interestingly, kidney involvement was as severe in the orally as the i.m.-treated animals.
INTRODUCTION
Large doses of mercury salts and other heavy metals produce acute toxic lesions, such as renal tubular necrosis (10) . In contrast, low doses of heavy metals may induce immunologically mediated diseases. Thus, membranous nephropathy has been described in humans in association with administration of mercury compounds (1 1). Several models ofchronic HgC1,-induced, immunologically mediated diseases have been established in the rat (5) and the rabbit (1 2). Sequential involvement of autoimmunization to connective tissue components and development of immune complex-mediated pathology has been demonstrated clearly for both species (1, 2, 7, 13) .
Almost all of the experimental diseases were induced by parenteral application of mercury compounds. Druet et a1 produced renal lesions in Brown-Norway (BN) rats by applying mercury-containing drugs to the skin, on wounds, into the vagina, and by mouth. Their findings provided strong evidence against the use of mercury-containing ointments and antiseptics (8) .
Roman-Franc0 et a1 demonstrated that rabbits * Presented at the Fourth International Symposium of the Society of Toxicologic Pathologists, June 5-7, 1985 in Washington, D.C., injected i.m. with HgCl, produced immune deposits in extrarenal tissues, such as the sinusoids of the liver, pen-and endomysium, and the lamina propria of the intestinc (1 3). Recently, immune deposits were documented in the intestines of three BN rats receiving HgCl, by gavage (4). However, none of the rats developed proteinuna; the kidneys, as studied by light microscopy (LM), appeared normal. Since mercury compounds are of growing importance as environmental pollutants (1 5) and ingestion seems to be the prevalent route of intake in man, we studied chronology and organ distribution of lesions induced by chronic oral administration of HgC12 and compared them to the disease after parenteral HgCl, application in BN rats. water three times a week from week 1 to 39 by gavage. Sixteen rats were injected i.m. twice a week with a sterile solution of HgCl, prepared with distilled water at a dosage of 100 pg HgC1,/100 g body weight; 4 of these animals were switched to oral treatment after 4 weeks. Due to an outbreak of sialodacryoadenitis virus-infection in the animal colony, no treatment or urine sampling was possible from weeks 5 to 10 in most of the rats. Animals were sacrificed at different times from weeks 2 to the end of the experiment at week 39. During this time, unilateral nephrectomies were performed in some ofthe animals. The rats were anesthetized with an i.p. injection of chloral hydrate.
METHODS

Aitittzals
Animal weights were determined every two months. Urine was collected for a 24 hour-period once a week, and the amount of protein in the urine was determined by the biuret method (9); at the same time, the urine specimens were tested for blood (Hemastix, Miles Laboratory, Inc., Elkhart, IN). Blood was collected every week by venipuncture.
Histology and Ininitiriopathology. For light microscopy, tissues were fixed in 10% buffered formalin and stained with hematoxylin and eosin (H&E), and periodic acid-Schiff (PAS) reagent. For direct immunofluorescence, 4 pm thick sections of snap-frozen specimens were incubated according to standard procedures with fluorescein-conjugated antisera to rat IgG, IgM, and C3 produced in the goat (1 3). Staining for IgA was performed using sheep antiserum to rat IgA and, as a second step-reagent, fluorescein-conjugated rabbit antiserum to sheep IgG. Cross-reactivity was absorbed with purified rat IgG. All antisera were purchased from Cooperbiomedical, Inc. (Malvern, PA).
Serology. Circulating anti-tissue antibodies were assayed by indirect I F using 4 pm thick cryostat sections of kidney, liver, and ileum from normal BN rats. Circulating immune complexes were studied using a modification (3) of the Raji cell immunofluorescence method (14) .
RESULTS
Cliriical Syrnptonu arid Laborat oty Findings
After 2 weeks of oral HgC12 administration, the rats lost weight and showed alopecia. However, the differences in weight between treated and control animals never were statistically significant. Marked alopecia areata developed in 2 of the animals after 10-14 weeks of oral treatment.
Proteinuria was first observed from weeks 5 to 8 in up to 50% of the rats. Starting at week 12 a mild proteinuria was detected in 15% ofthe animals. The frequency ofproteinuric rats increased to -50% from weeks 23 to 30 and to -75% from weeks 32 until the end of the experiment; proteinuria was persistent. Proteinuria exceeding 50 mg proteid24 hours was observed only after week 23. However, four of the 16 orally treated animals never developed proteinuria.
In contrast, i.m.-treated rats showed an early phase of proteinuria starting in weeks 2-4. In weeks 5 and 6,5 of the 16 i.m.-treated rats died. Despite the lack of information about protein excretion in these animals, this finding correlates well with the heavy proteinuria and subsequent death found in a large proportion of BN rats after 4-5 weeks of i.m. treatment as reported by Albini et a1 (2).
Im r n it noii istological Fir idiiigs
Light Microscopy. All of the control animals showed normal tissue structures. In weeks 4 and 5 of oral HgCI, administration, a mild thickening of glomerular basement membrane (GBM) and Bowman's capsule was observed in 3 out of 4 animals. In one rat, focal thickening of tubular basement membrane (TBM) and interstitial nephritis was seen ( Fig. la) . This animal also showed increased frequency and size of resorption droplets in tubular epithelia of some nephrons.
Three of 4 animals sacrificed at weeks 6, 11, 14, and 18, respectively, presented moderate thickening of GBM, mesangial matrix, and TBM. One animal had extensive, albeit still focal, interstitial nephritis and showed mild changes of podocytes and Bowman's capsuIe ( Fig. 2a) .
In six rats sacrificed or nephrectomized between weeks 20 and 32, only mild to moderate thickening of kidney basement membrane (BM) and increased frequency and size of resorption droplets in tubular epithelia could be demonstrated. Glomerular pathology was suggestive of membranous lesions.
At week 39, all three rats with proteinuria showed thickening of GBM and marked increase of the mesangial matrix. In addition, one of the animals had severe interstitial lesions with infiltrates consisting predominantly of plasma cells (Fig. 3a) , whereas the other two rats showed only minimal interstitial infiltration by mononuclear cells. The non-proteinuric animals had only mild changes of the kidney structures. Light microscopic study of intestinal tissues showed no well-defined changes. Rats injected i.m. with HgC12 developed glomerular lesions as described in earlier reports (2). Interestingly, interstitial lesions were absent from this group. Itntniiriofluorescetice. Control rats showed no reactivity with the antisera used. After 2 weeks of oral administration of HgC12, and throughout the whole observation period, kidneys showed linear deposits of IgG, IgM, and IgA. The staining pattern for IgG deposits in an animal sacrificed at week 5 is seen in Fig. lb. After week 11, weak granular deposits were observed first in the TBM (Fig. 2b) and later in the GBM (Fig. 2c) .
Rats sacrificed at week 39 showed more prominent granular deposits along GBM and TBM, together with a concomitant decrease of the linear staining (Fig. 3b) . Staining for complement became positive only in the last weeks of the experiment.
Intestinal tissues initially showed linear staining for IgG, IgM, and IgA in the BM. During the last weeks of the experiment, extensive granular deposits were seen predominantly in intestinal capillaries, but also, segmentally, in the intestinal BM.
In rats injected i.m., linear and granular staining for IgG and IgM along GBM and TBM followed the pattern described earlier (2). In most animals, GBM, and to a lesser extent TBM, showed linear staining with an antibody to rat IgA (Fig. 4) . Intestinal BM of rats injected i.m. also presented deposits of all three Ig.classes.
Sero!ogy. IgG antibodies to BM detectable in indirect IF at a dilution of 1 : 10 were present in sera of most animals with oral or 'i.m. treatment from week 3 to week 1 1. Already at week 1 1, the staining became either very weak or was not present in some rats treated orally. Serum antibodies of other Ig classes could not be documented. Untreated rats never showed positive tests for serum antibodies to BM.
Circulating immune complexes of the IgG class were first detected in week 3, remained at high titers 192 KNOFLACH ET AL TOXICOLOGIC PATHOLOGY (> 1:16 or 1:32) until week 17. The titers decreased over the later period of the experiment. Circulating immune complexes containing IgA never could be demonstrated. Sera of control animals remained negative for circulating immune complexes except during the viral infection, where titers up to 1:8 were found.
DISCUSSION
Kidney involvement after oral administration of mercury compounds in rats was first suggested by Druet et a1 (8) . They observed proteinuria and granular immune deposits in five BN rats that received calomel by gavage for two months. Development of the disease and histopathology were not described in detail. However, in a recent report by Andres (4), a careful analysis of kidney immunopathology of three BN rats treated orally with HgCI, for two months revealed only minimal and segmental granular deposits of IgG and occasionally of C3 in glomerular mesangia and capillary walls. No histopathology or proteinuria was observed. In contrast, our study shows that 12 ofthe 16 rats treated orally with HgCl, did develop proteinuria during the observation period of 39 weeks. All 16 animals showed in vivo bound Ig along kidney BM and had mild to severe histopathological changes. To explain the high incidence of renal disease in our study, a number of factors may be considered. First, these rats went through a brief period of viral infection. However, in four out of the 16 animals treated orally, the administration of HgCl, was initiated only several weeks after the viral infection subsided; some of the animals with most severe kidney disease were from this group. In addition, the progression and character of the kidney disease in rats receiving HgCl, i.m. followed the pattern described earlier (2, 7). Second, the experiment reported here used a large number of animals and the observation period also was rather long.
The development of the kidney disease after oral HgC12 administration was comparable to that observed in rats receiving HgCl, i.m. This was true in general for serology, immunohistology, histopathology, and urinalysis. However, rats injected with HgC1, i.m. had a higher lethality than orally treated rats. In addition, onset of proteinuria occurred later in orally than i.m.-treated animals. Interestingly, interstitial nephritis was observed in orally treated animals much more frequently than documented for i.m.-injected animals in the earlier literature or in this report. Immune complex deposits in peritubular capillaries seemed to appear earlier and more frequently in the orally treated rats. Further analysis of this finding obviously is required to understand the pathogenesis of this lesion. The systemic nature of the HgCl, induced disease in experimental animals has been documented in a number of reports. The gastrointestinal tract was also among the tissues involved (2,4, 6, 8, 12, 13) . It seemed especially interesting to determine if the intestinal involvement in BN rats treated orally differed from that of i.m.-injected rats. The results obtained in this study, comparing 16 orally treated to 16 i.m.-injected rats, strongly suggest that the immune deposits found in the intestine do not differ. In both animal groups, IgG, IgM and IgA were first present in a linear and then in a granular fashion in BM of the intestines. A detailed report on intestinal pathology, including functional studies, will be published separately.
Linear and granular IgA deposits were observed both in intestinal and renal tissues of both orally and intramuscularly treated rats. The specificity of the staining was established by immunoelectrophoresis and absorption studies ofthe conjugates. It thus seems likely that antibodies to BM of the IgA class are synthesized both upon oral and i.m. administration of HgC1,. The absence of detectable IgA antibodies and immune complexes in the circulation may be explained by low titers of these immune reactants; however, this requires further experimentation.
These findings demonstrate that chronic oral administration of HgCl, may lead t o overt renal and intestinal pathology in BN rats. This seems highly relevant in view of the frequency of water contamination with mercury compounds.
